Systemic mastocytosis with renal light chain amyloidosis: associated non-mast cell disorder or concurrent disease
Systemic mastocytosis with an associated hematological neoplasm (SM-AHN) is a rare diagnosis commonly associated with myeloid disorders. Herein, we describe the case of a 53-year-old female diagnosed with systemic mastocytosis (SM) in conjunction with renal light chain amyloidosis (AL) and smoldering myeloma. Although cytokines such as IL-6 may play a role in the proliferation of plasma cells, delays in the diagnosis of SM and paucity of relevant studies cast uncertainty on whether the associated disease is secondary to the mast cells or etiologically independent. To our knowledge, this is the first case of confirmed renal AL disease in conjunction with SM. We review and summarize the available literature describing SM in association with plasma cell disorders.
KeywordsSystemic mastocytosis Plasma cell disorder Amyloidosis
Compliance with ethical standards
Conflict of interest
The authors declare that they have no conflict of interest.
- 11.Sotlar K, Saeger W, Stellmacher F, Stahmer J, Jackle S, Valent P et al (2006) “Occult” mastocytosis with activating c-kit point mutation evolving into systemic mastocytosis associated with plasma cell myeloma and secondary amyloidosis. J Clin Pathol 59(8):875–878CrossRefPubMedPubMedCentralGoogle Scholar
- 17.Ghanem S, Garcia G, Ying L, Hurford M, Odaimi M (2016) Systemic mastocytosis with smoldering multiple myeloma: report of a case. Case Rep Oncol Med 2016(3161768):1–6Google Scholar
- 26.Schmidt-Hieber M, Perez-Andres M, Paiva B, Flores-Montero J, Perez JJ, Gutierrez NC, Vidriales MB, Matarraz S, San Miguel JF, Orfao A (2011) CD117 expression in gammopathies is associated with an altered maturation of the myeloid and lymphoid hematopoietic cell compartments and favorable disease features. Haematologica 96(2):328–332CrossRefPubMedGoogle Scholar